Curatis Holding AG (SWX:CURN)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
12.55
+0.65 (5.46%)
At close: Dec 5, 2025
-4.92%
Market Cap 63.22M
Revenue n/a
Net Income n/a
Shares Out 5.04M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 83
Average Volume 1,523
Open 11.75
Previous Close 11.90
Day's Range 11.75 - 12.55
52-Week Range 9.14 - 15.80
Beta n/a
RSI 50.35
Earnings Date n/a

About Curatis Holding AG

Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson’s disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ antibioticum, gentamycin collagen sponge, benign prostatic hy... [Read more]

Sector Healthcare
CEO Roland Rutschmann
Employees 20
Stock Exchange SIX Swiss Exchange
Ticker Symbol CURN
Full Company Profile

News

There is no news available yet.